☆ 4.5 Editorial Material

Explanations for the difference in rates of cardiovascular events in a trial of alendronate and romosozumab

OSTEOPOROSIS INTERNATIONAL (2020)

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Fracture Prevention with Zoledronate in Older Women with Osteopenia

Ian R. Reid et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Add to Collection
Article Medicine, General & Internal

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

Kenneth G. Saag et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Add to Collection
Review Cardiac & Cardiovascular Systems

Bisphosphonates for cardiovascular risk reduction: A systematic review and meta-analysis

Guido Kranenburg et al.

ATHEROSCLEROSIS (2016)

Add to Collection
Article Medicine, General & Internal

Romosozumab Treatment in Postmenopausal Women with Osteoporosis

F. Cosman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.